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Objective: Airway hyperresponsiveness is the main feature of asthma and also exists in cigarette
smokers. In previous studies we have shown increased airway responsiveness to isoprenaline in asth-
matic patients and smokers. In this study, tracheal responsiveness to isoprenaline and β-adrenergic
receptor blockade was investigated in animals exposed to cigarette smoke (AECS) with or without
sensitization by ovalbumin (OA).
Methodology: Guinea pigs were exposed to cigarette smoke over a 3-month period with or without
sensitization by injection and inhalation of OA. Tracheal responses in AECS, AECS + sensitized and
control animals (n = 7 for each group) to isoprenaline in the absence and presence of 20 nmol/L pro-
pranolol were measured and EC50 was established. The propranolol blockade (concentration ratio
minus one (CR-1)) was calculated (post-propranolol EC50/EC50) − 1.
Results: The tracheal response of AECS and AECS + sensitized guinea pigs to isoprenaline was sig-
nificantly higher than that of control animals (EC50: 4.24 ± 0.54, 3.66 ± 0.53 and 7.71 ± 0.68.79 µmol
for AECS, AECS + sensitized and control animals, respectively) (P < 0.001). There was no significant
difference in EC50 between AECS and AECS + sensitized. CR-1 was also significantly higher in the
trachea of AECS and AECS + sensitized compared with controls (13.39 ± 2.22 and 15.35 ± 2.95 vs.
3.10 ± 0.6, P < 0.05 in both cases). There was no significant difference in CR-1 between AECS and
AECS + sensitized. There was a significant correlation between the tracheal response to isoprenaline
(EC50) and CR-1 (r = −0.731, P < 0.001). There was no significant difference in tracheal maximum
response to isoprenaline between the three groups of animals.
Conclusions: The results of this study indicate an increased tracheal response to a β2-adrenergic
stimulating drug and enhanced β2-adrenergic blockade by propranolol in both AECS and
AECS + sensitized. These results suggest similar increase in airway responsiveness to β2-adrenergic
agonists and β2-receptor blockade in AECS and AECS + sensitized guinea pigs.
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INTRODUCTION
COPD is a global health problem, reaching almost
epidemic proportions in the developing world.1
Understanding the basic mechanisms of this disease
and the development of new treatment(s) to prevent
the progression presents a major challenge.
In cigarette smokers airflow obstruction is caused
by parenchymal disease (emphysema) and/or by
smoke-induced distortion of the structure of the
small airways.2–4 Investigation of the mechanisms of
cigarette smoke-induced disease can be facilitated by
using an animal model in which guinea pigs develop
airflow obstruction and emphysematous lung
destruction.5
One of the most characteristic features of asthma
is  bronchial  hyperresponsiveness  to  a  wide  variety
of  inhaled  physical,  chemical,  pharmacological
and immunological stimuli. However, airway
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hyperresponsiveness  (AHR)  to  different  stimuli  is
also  observed  in  animals  exposed  to  cigarette
smoke (AECS).6–10
Controversy exists regarding bronchial responsive-
ness to β2-adrenergic agonists in asthma. Previous
studies have shown very similar dose–response rela-
tionships to β-agonists in normal and asthmatic sub-
jects.11–14 Our previous studies showed an increased
bronchial responsiveness to isoprenaline in asthmat-
ics compared with normal subjects,15 in sensitized
compared with control animals16 and in epithelium
denuded trachea compared with intact epithelium
trachea.17 In addition, in recent studies, increased air-
way responsiveness to salbutamol in smokers com-
pared with non-smoking subjects and asthmatics has
been demonstrated.18,19
In the present study the effect of cigarette smoke on
airway responsiveness to the β-agonist isoprenaline
and to β2-adrenergic blockade by propanolol was
studied by examining tracheal responsiveness of
guinea  pigs  exposed  to  cigarette  smoke  alone,
and exposed to cigarette smoke and sensitized to
ovalbumin (OA).
MATERIALS AND METHODS
Animals, cigarette smoke exposure and 
sensitization
Twenty-one adult Dunkin-Hartley guinea pigs of both
genders and weighing 400–500 g were divided into
three groups: one group was exposed to cigarette
smoke only (AECS), one exposed to cigarette smoke
and sensitized to OA (AECS + sensitized) and one
control group (n = 7 for each group).
Experimental animals were exposed to cigarette
smoke as previously described.20,21 The animals were
exposed to cigarette smoke in an awake, restrained
state and spontaneously breathing in a smoking
chamber which was a modification of that described
by Simani and coworkers.20 Animals were placed in a
Plexiglas box with their heads secured in a compart-
ment (15 cm × 12 cm × 7 cm). A syringe delivered the
cigarette smoke. Twenty millilitre puffs of cigarette
smoke were drawn out of the cigarettes with syringes
and then exhausted at a rate of two puffs per minute
into the animals’ chamber. Exposure of animals to
each cigarette lasted for 8–9 min, with a 10-min rest-
ing period between cigarettes. The animals were
exposed initially to one commercial non-filter ciga-
rette per day gradually increasing to a maximum of
five cigarettes per day over a 2-week period. In a pilot
study it was observed that animals could not tolerate
the exposure to cigarette smoke of more than five
cigarettes  per  day.  The  exposure  to  the  smoke  of
five cigarettes per day, 6 days per week, continued for
3 months. The control animals were not exposed to
cigarette smoke and kept in an animal house in
normal conditions for the same period of time.
Sensitization of animals to OA was performed using
the method described by McCaig.22,23 Briefly, seven
guinea pigs were sensitized to OA (Sigma Chemical
Ltd, Poole, Dorset, UK) by injecting 100 mg i.p. and
100 mg s.c. on day 1 and a further 10 mg i.p. on day 8.
From day 14 sensitized animals were exposed to an
aerosol of 4% OA for 18 ± 1 days, 4 min daily. The aero-
sol was administered in a closed chamber, dimen-
sions 30 cm × 20 cm × 20 cm.
Tissue preparations
Guinea pigs were killed by a blow to the neck and the
trachea removed. Each trachea was cut into 10 rings
(each containing two to three cartilaginous rings). All
the rings were then cut open opposite the trachealis
muscle, and sutured together to form a tracheal
chain.23,24 The tracheal chain was then suspended in a
10-mL organ bath (organ bath 61 300, BioScience
Palmer-Washington, Sheerness, Kent, UK) containing
a Krebs-Henseleit solution of the following composi-
tion (mmol/L): NaCl 120, NaHCO3 25, MgSO4 0.5,
KH2PO4 1.2, KCl 4.72, CaCl2 2.5 and dextrose 11.
The Krebs-Henseleit solution was maintained at
37°C and gassed with 95% O2 and 5% CO2. The tra-
cheal chain was suspended under an isotonic tension
of 1 g and allowed to equilibrate for at least 1 h while
it was washed with Krebs solution every 15 min.
Measurement of tracheal response to 
isoprenaline and b2-receptor blockade
In each experiment two cumulative log concentra-
tion–response curves of isoprenaline sulphate (Sigma
Chemical Ltd) induced relaxation of precontracted
tracheal chains were obtained. One of the curves was
performed 10 min after producing a 20 nmol/L con-
centration of propranolol hydrochloride (Sigma
Chemical Ltd) in the organ bath (post-propranolol
response curve), and the other 10 min after adding
the same volume of saline to the bath (baseline
isoprenaline response curve). Isoprenaline con-
centrations were increased every 2 min (range from
10 nmol/L to 100 µmol/L), and the percentage of
relaxation due to each value of isoprenaline concen-
tration in proportion to the maximum contraction
obtained with 10 µmol/L methacholine (Sigma
Chemical Ltd) alone was plotted against the log
concentration of isoprenaline.
The effective concentration of isoprenaline causing
50% of maximum response (EC50) alone or post pro-
pranolol was measured and expressed as EC50 and
post-propranolol EC50, respectively. The isoprenaline
EC50 for tracheal responses in the three animal groups
were calculated and compared. The β2-adrenergic
receptor blockade by propranolol was assessed as the
concentration ratio minus one (CR-1) which was cal-
culated by: (post-propranolol EC50/baseline EC50) − 1.
Pathological evaluation
The lungs of some AECS and AECS + sensitized were
randomly selected for normal pathological evaluation
using haematoxin-eosin dye.
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Statistical analysis
The data for the tracheal response to isoprenaline
(EC50), β2-adrenergic blockade (CR-1) maximum
response and haematocrit were quoted as
mean ± SEM. In comparing all values between AECS,
AECS + sensitized and control guinea pigs ANOVA
with Tukey-Kramer post test was used. Tracheal
response to isoprenaline (EC50) was related to (CR-1)
using the least square regression. Significance was
accepted at P < 0.05.
RESULTS
Histology
The following pathological changes were observed in
the lungs of AECS (Fig. 1): increased interalveolar sep-
tum in all specimens, increased lymphatic tissue in
the lung parenchyma of all specimens, the destruc-
tion of alveolar wall and existence of emphysema in
the lung of most animals and intra-alveolar bleeding
in most of the animal lungs.
In addition, the following pathological changes
were observed in the lungs of AECS + sensitized
(Fig. 1): epithelial damage and parenchymal
eosinophilia.
Tracheal response to isoprenaline
The mean value of isoprenaline EC50 in tracheal
chains of AECS (4.24 ± 0.54 µM, range 2.8–6.0) was
significantly lower than in control animals
(7.71 ± 0.68 µM, range 5–10, P < 0.001) (Table 1,
Fig. 2a). The most responsive trachea of AECS was 3.6
times more sensitive to isoprenaline than the least
responsive trachea from control animals.
The mean value of EC50 in tracheal chains of
AECS + sensitized (3.66 ± 0. 53 µM, range 2.0–6.0) was
significantly lower than in control animals (P < 0. 01)
(Table 1, Fig. 2a). The most responsive trachea of
AECS + sensitized was five times more sensitive to
isoprenaline than the least responsive trachea from
control animals. However, there was no significant
difference in EC50 between AECS and AECS +
sensitized.
Beta-adrenergic blockade (CR-1)
The rightward shift of the post-propranolol isoprena-
line response curve compared with the baseline iso-
prenaline response curve in tracheal chains of AECS
was greater than that of control animals (Fig. 3). Mean
CR-1 in tracheal chains of AECS (13.39 ± 2.22, range
7.5–25.0) was 4.32 times greater than in control ani-
mals (3.10 ± 0.63, range 1.20–5.42, P < 0. 05) (Table 1,
Fig. 2b). The value of CR-1 of the most sensitive tra-
chea of AECS animals was 20.1 times greater than that
for the least sensitive trachea from control animals.
The rightward shift of the post-propranolol isopre-
naline response curve compared with the baseline
isoprenaline response curve in tracheal chains of
AECS + sensitized was greater than that of control
animals (Fig. 3). Mean CR-1 in tracheal chains of
AECS + sensitized (15.35 ± 2.95, range 6.00–24.00) was
4.95 times greater than in control animals (P < 0.05)
(Table 1, Fig. 2b). The value of CR-1 of the most sen-
sitive trachea of AECS was 20.0 times greater than that
of the least sensitive trachea from control animals.
However, there was no significant difference in the
value of CR-1 between AECS and AECS + sensitized.
Relationship between bronchial response to 
isoprenaline and propranolol blockade
There  was  a  significant  negative  correlation  bet-
ween tracheal  response  to  isoprenaline  (EC50)  and
Figure 1 Photomicrograph of a lung specimen from con-
trol guinea pig (a) and from COPD animals (b,c), and a lung
specimen of animals exposed to cigarette smoke and sensi-
tized to ovalbumin (AECS + sensitized; d) showing smoke
particles (SPP), alveolar wall thickening (AWT), increased
lymphoid tissues (LT), emphysema (EM) and epithelial
damage (ED).
LT
AWT
(b)
(a)
(d)
(c)
EM 
ED
SPP
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β-adrenergic blockade by propranolol (r = −0.731,
P < 0.01; Fig. 4).
Maximum response to isoprenaline
There was no significant difference between the mean
values of maximum response to isoprenaline in tra-
cheal chains of AECS (85.86 ± 3.31), AECS + sensitized
(89.57 ± 5.51) and control animals (92.17 ± 6.05)
(Table 1, Fig. 3).
DISCUSSION
This study showed increased tracheal response to iso-
prenaline in guinea pigs exposed to cigarette smoke
and exposed to smoke + sensitized to OA compared
with control animals. The histological findings in
AECS showed increased interalveolar septum and
lymphatic tissue, destruction of alveolar walls and
intra-alveolar bleeding as was to that observed in
previous studies.5,25,26 The increased tracheal response
to isoprenaline in AECS + sensitized confirmed the
induction of experimental asthma and the tracheal
responsiveness to a β-agonist drug was similar to our
previous studies.15–18
Several other studies have shown AHR to differ-
ent stimuli in guinea pig exposed to cigarette
smoke.6–10 However, the present study demon-
strated an increased tracheal responsiveness to
isoprenaline  and  β-adrenergic  receptor  blockade
by propranolol (CR-1) in both AECS and
AECS + sensitized. The increased receptor blockade
by a competitive antagonist was similar to previous
studies indicating increased muscarinic, histaminic
(H1) and β-adrenergic blockade by atropine,27
chlorpheniramine28 and propranolol16 in sensitized
guinea pigs, respectively. The consistent increase in
antagonist blockade in the present study and in our
previous studies in sensitized animals,16,27,28 indi-
cates that the cause of enhanced receptor blockade
is due to an increase of either receptor affinity (Ka)
and/or drug delivery to the receptors ([I]).29 The fact
that three receptor systems showed enhanced com-
petitive antagonist blockade in sensitized
animals16,27,28 and one receptor system in cigarette
exposed animals in in vitro studies suggests that the
abnormality lies with [I] rather than Ka. This conclu-
sion is also supported by in vitro experiments, that
demonstrate that receptor affinity for a given antag-
onist shows little variation between species and
tissues.30 We therefore suggest that this enhanced
antagonist blockade is caused by epithelial damage
leading to increased epithelial permeability and
accessibility of ligands to the receptor sites.
Increased airway inflammation and epithelial per-
meability to different agents has been demonstrated
in asthmatic patients, AECS and in smokers.20,21,31–39
The pathological findings in the present study
showed lung tissue inflammation in both AECS and
AECS + sensitized groups. The association between
airway inflammation, epithelial damage and AHR has
been reported both in sensitized animals40 and in
asthmatic patients.41
However, our previous studies15,42,43 showed
enhanced blockade when pharmacological antago-
nists were administered by i.v. injection in asthmatic
patients; and this cannot be due to increased airway
epithelial permeability possibly this occurred due to
increased tissue permeability secondary to airway
inflammation and would explain the variation in (CR-
1) produced by both routes of administration. Fur-
thermore, the results of the present in vitro study
cannot be fully explained by increased airway epithe-
lial permeability as the barrier role of epithelium
against ligand diffusion44 will only occur if the tra-
cheal or bronchial tubes are exposed to ligands from
the mucosal side. In our model, suspended tracheal
rings were used and thus non-epithelial surfaces were
exposed. Pathological examination did not show
obvious airway epithelial damage in AECS animals
although there was epithelial damage in the airways
of AECS + sensitized guinea pigs.
The increased propranolol blockade in tracheal
chains of AECS and AECS + sensitized guinea pigs, as
well as the increased chlorpheniramine, atropine, and
propranolol blockade in our previous in vivo studies
in asthmatic patients15,42,44 and enhanced atropine,
chlorpheniramine and propranolol blockade in tra-
cheal chains of sensitized animal studies,16,27,28 could
be  due  to  higher  concentration  of  antagonists  at
the receptor sites achieved by an increased epithelial
and tissue permeability leading to an increase in [I].
Destruction of lung parenchyma has been
documented in AECS21 and thus, increased tissue
Table 1 Tracheal response to isoprenaline (EC50), β-receptor blockade by propranolol (CR-1), haematocrit and maximum
relaxation response to isoprenaline in tracheal chains of control, cigarette exposed (AECS) and cigarette exposed + sensitized
(AECS + sensitized) animals and statistical differences between the three groups (n = 7 for each group)
Tracheal response Control AECS AECS + sensitized
EC50 (µmol) 7.71 ± 0.68 4.24 ± 0.54*** 3.66 ± 0. 53*** ns
(CR-1) 3.10 ± 0.63 13.39 ± 2.22* 15.35 ± 2.95* ns
Maximum response 92.17 ± 6.05 85.86 ± 3.31 NS 89.57 ± 5.51 NS ns
Haematocrit 21.80 ± 0.91 34.57 ± 2.13*** 37.16 ± 2.02*** ns
Values are quoted as mean ± SEM.
Statistical differences between values in AECS and AECS + sensitized groups with those of control animals: NS; non-
significant, *P < 0.05, ***P < 0.001; Statistical differences between values in AECS with AECS + sensitized groups: ns;
non-significant.
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permeability  and  better  accessibility  of  ligands  to
the receptor sites is possible.
There was also a significant correlation between β-
adrenergic receptor blockade by propranolol (CR-1)
and tracheal response to isoprenaline and histamine.
These data as well as that from our previous
studies15,42,43 suggest that bronchial hyperresponsive-
ness to different stimuli in AECS and asthma is due at
least in part to increased bronchial tissue permeabil-
ity. If substantiated, the treatment should be focused
on preventing increased permeability.
Using a similar method to the present study but
with exposure periods of 2 h/day for 2 weeks,
enhanced bronchial smooth muscle contraction
Figure 2 Individual values (, , ) and mean ± SEM
(larger symbols with error bars) of tracheal response to iso-
prenaline (EC50) (a), β-receptor blockade by propranolol
(CR-1) (b) and haematocrit (c) in (, ) tracheal chains of
control, (, ) animals exposed to cigarette smoke (AECS),
and (, ) AECS + sensitized animals (n = 7 for each group).
Statistical differences between values in AECS and
AECS + sensitized groups with those of control animals:
*P < 0.05, ***P < 0.001. Statistical differences between values
in AECS with AECS + sensitized groups: NS, non-significant.
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induced by cigarette smoke exposure was shown.45
Our previous study also showed an increased tracheal
responsiveness to methacholine in cigarette smoke
exposed guinea pigs.46 Although, there are reports
regarding the effect of smoking on enhanced airway
responsiveness both in atopic humans47 and sensi-
tized animals,48 the novel findings of the present in
vitro study that there was a similar tracheal respon-
siveness to isoprenaline and β-adrenergic blockade
(CR-1) in AECS and AECS + sensitized guinea pigs.
These results suggest that airway responsiveness to β-
agonists in early phase of AECS is similar to that of
asthma and induction of asthma does not add further
increase in this phenomenon. In addition, there was
no significant difference in the maximum relaxant
effect to isoprenaline between the three groups of
animals (control, AECS and AECS + sensitized). These
findings may indicate that maximum relaxation
response to β-agonist drugs is more likely to occur in
early phase of AECS.
The other possible explanation for the findings of
the present study is an upregulation and increased
expression of the receptors due to both sensitization
and cigarette smoke However, upregulation and
increased expression of the receptors would result to
increased tracheal responsiveness to isoprenaline
without affecting β-blockade and therefore this seems
unlikely.
This study demonstrated similar increases in tra-
cheal response to isoprenaline and enhanced adren-
ergic receptor blockade by propranolol in AECS and
AECS + sensitized guinea pigs. These results suggest
similar increases in airway responsiveness to β-
adrenergic agonists and β-receptor blockade in AECS
and AECS + sensitized guinea pigs and that maximum
relaxation response to β-agonist drugs is obtainable
only in early phase of AECS.
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